President's Note
After a foundational 5 year period, VEIO is starting a fresh phase of strong growth, to become the CRO of choice in the CEE region with plans to grow and develop beyond CEE.
With proven, qualified team of financial experts, led by its newly appointed CFO, Mr. Victor D’Arcy Smith, VEIO is fully equipped to provide top-class services to its clients, from trial planning, setting and management, up to support in fund raising and fund-management.
We continue to attract and retain a high caliber of clinical research staff, which remains central to our aim of delivering a consistently high quality of service to our customers.
WHY CEE/SEE
Advantages of Outsourcing Clinical Trials to CEE/SEE
Market Opportunity
The number of clinical trials have more than doubled over the last five years
Patient Access
Presence of large untreated patient population and population's geographical stability that facilitates easier patient follow-up
Healthcare system
Highly specialized treatment centers and centralized healthcare system
Investigators
Availability of internationally well-educated and experienced investigators
About us

VEIO Research Limited was incorporated in 2005 by clinical research professionals who were pioneers in the CRO space within the CEE region (having built, rapidly grown and sold their first CEE focused CRO business to a trade buyer – a larger competitor and former strategic partner).
The Company collaborates with sponsors in conducting clinical trials, from inception to design and finalisation of protocol to obtain regulatory approvals.














